Join Us for a Diagnostic Challenge! A Virtual Case Study: A 51-Year-Old Female With a History of Crohn's Disease and Intestinal Resection*

*This is a hypothetical case and not an actual patient.

Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage.

Disclosures

• This program is sponsored by Takeda and speakers are paid consultants of Takeda.
• This presentation is not a CME activity.
• The information contained within this presentation is consistent with FDA guidelines.
• This is a hypothetical case and patient.

Course Summary

Jorge Vazquez, MD, MD Internal Medicine Specialist, Allegheny Center-Digestive Health Pittsburgh, PA

The keynote will start off by exploring the nationwide landscape of NP practice, resistance/acceptance of full practice authority, and the predictable turning of “green” in all 50 states. This is followed by 5 -7 recommendations to enable NPs to thrive personally and professionally in their full practice authority (green) environment.

Course Summary

Amelie Hollier, DNP, FNP-BC, FAANP, President, CEO, Advanced Practice Education Associates (APEA)

In 60 minutes, this presentation gives an update to prescribers on some of the most important clinical issues for prescribing APRNs in primary care. The participant will receive an update on COVID vaccines, treatment, and testing. Antibiotic stewardship is included with discussion about the latest in treatment duration of sinusitis, community-acquired pneumonia, and cellulitis as well as management of infection with C. diff. A broad overview of monoclonal antibodies and their importance in patients with cancer and many chronic diseases round out this presentation.

Course Summary

Amelie Hollier, DNP, FNP-BC, FAANP, President, CEO, Advanced Practice Education Associates (APEA)

This presentation will explore efficacy and safety data for 2 GLP-1 RA options for adults with T2D. A data review from select pivotal glycemic control trials as well as cardiovascular outcomes data will be presented.

Disclosures

 Product Theater session sponsored by Novo Nordisk. This is a promotional education presentation; it will not be certified for continuing medical education credit.

Course Summary

Lucia M. Novak, MSN, ANP-BC, BC-ADM, President and Owner Diabetes Consulting Services North Bethesda, Maryland Co-Executive Director Capital Health & Metabolic Center of Capital Diabetes & Endocrine Associates Camp Springs and Silver Spring, Maryland;, 

Selecting, interpreting, and managing laboratory tests are essential to quality care and often is a complex and challenging process. Selecting the appropriate test involves both art and science, involving knowledge of the test’s sensitivity/specificity, relevant evidence, cost, understanding of the patient and the condition as well as a measure of intuition. Interpreting labs is much more complicated than determining if the results are normal or abnormal. Clinicians need to develop a strategy or system for selecting and reviewing labs with the specific patient in mind. This presentation will guide participants in evaluating labs using a systematic approach to selection, interpretation, and management in the context of case studies.

Course Summary

Susan Feeney, DNP, FNP-BC, Assistant Professor; Director of NP Tracks, UMMS Graduate School of Nursing, FNP; Worcester State Student Health Center

Back Pain is among the top 10 chief complaints seen by clinicians in primary care out of 12 countries across 5 continents. In this presentation, common spine disorders managed in primary care will be reviewed. History and physical exam, imaging pearls, and scope of practice will be discussed.

Course Summary

Karen M. Myrick, DNP, APRN, FNP, ANP, ONP, FAAN, Associate Professor, University of Saint Joseph, Interdisciplinary Health and Science, Nurse Practitioner, Orthopedics Associates of Hartford

With a growing national shortage of primary care physicians, today’s complex and dynamic healthcare environment increasingly places nurse practitioners (NPs) and PAs as front-and-center clinical managers of infectious diseases like influenza and the global COVID-19 (SARS-CoV-2) pandemic makes these frontline clinicians more important than ever before. Influenza and SARS-CoV-2 viruses can cause similar symptoms, making differential diagnosis difficult and even more confounding to clinicians, patients can be coinfected with both SARS-CoV-2 and influenza viruses simultaneously. The global impact of COVID-19 has resulted in rapid, ongoing changes to influenza practice guidelines. This educational initiative will provide a concise, case-based, expert-led review of the latest clinical practices and best available evidence for effective influenza management, targeted to the unique needs of NPs and PAs.

Learning Objectives

After completing this activity, the participant should be better able to

• Recognize patients who would most benefit from antiviral therapy based on the risk of influenza-related complications, in accordance with evolving recommendations in the COVID-19 era.
• Distinguish influenza from other viral infections in patients based on signs, symptoms, and test results in the COVID-19 era
• Develop individualized antiviral treatment plans that are safe and effective for patients with, or at risk of, influenza and/or possible co-infections in the rapidly evolving COVID-19 era.

Course Summary

Ruth Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP, Professor and FNP, University of Louisville School Medicine, Division of Infectious Diseases

Learn more about the relationship between chronic kidney disease (CKD) and diabetes, and the impact of these comorbidities on patients. This presentation will review the definition, clinical characteristics, and epidemiology of CKD. It will explore the implications of diabetes as a coexisting morbidity and discuss the challenges that patients and healthcare providers face in managing these concurrent conditions. Additionally, it will highlight the importance of a collaborative approach to care for patients with CKD and diabetes.

Disclosures

Product Theater session sponsored by Boehringer-Ingelheim & Lilly (Golin). This is a promotional education presentation; it will not be certified for continuing medical education credit.

Course Summary

Debbie Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse and Certified Diabetes Educator, Memorial Hospital Diabetes Center, University of Colorado Health

In this session, you will learn about the latest epidemiology related to post-menopausal hot flashes, atrophic vaginitis/genitourinary syndrome of menopause and low libido. The pathophysiology, diagnostic workup, and management will be updated including pharm, nonpharm approaches, and patient education.

Course Summary

R. Mimi Secor, DNP, FNP-BC, FAANP, FAAN, NP, National Speaker, Senior Faculty with APEA

Description

Course Summary

Christine Kessler, MN, ANP, CNS, BC-ADM, CDTC, FAANP, Founder and Clinical Consultant, Metabolic Medicine Associates

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.

Disclosures

Product Theater session sponsored by Boehringer-Ingelheim (Golin). This is a promotional education presentation; it will not be certified for continuing medical education credit.

Course Summary

Matthew Budoff, MD, Professor of Medicine, UCLA Endowed Chair of Preventive Cardiology, Lundquist Institute Torrance, CA

​Norman E. Lepor, MD FACC, , 

Since the landmark 1998 Adverse Childhood Experiences (ACEs) study from the Centers for Disease Control and Prevention and Kaiser Permanente, a paradigm shift has occurred in the healthcare approach to adult disease. We now recognize ACEs are a significant contributor to adverse holistic health outcomes including predisposition to the risk of depression, heart disease, overweight/obesity, asthma, cancer, and many others. Evidence is emerging to demonstrate how complex trauma can impact biology and genetic composition. This session will explore the health impacts of ACEs and equip providers to foster protective factors and resilience in a trauma-informed and culturally responsive way.

Course Summary

Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, Clinical Professor, Baylor University

The Nurse Practitioner in the Primary Care setting is challenged in the treatment of ASCVD to provide the most up-to-date goals, treatment guidelines, and expectations for primary vs secondary prevention. This program will sift through the complicated updates of the past few years and allow the nurse practitioner to incorporate these into their practice.

Course Summary

Gary Graf, MSN, ARNP-C, Family Nurse Practitioner (BC), Cotton-O'Neil Diabetes and Endocrinology Center

Learn about the statistics on stress and mental health problems in the US including the effects of the pandemic. The effects of stress, the definition of extreme stress and extreme self-care and resilience will be explored. The benefits of self-care and building resilience will be also be discussed. How to cope with extreme stress, break unhealthy habits and establish healthy habits will also be described. Innovative strategies like habit stacking will be presented with examples. This post-pandemics session will help you improve your health including your mental health.

Course Summary

R. Mimi Secor, DNP, FNP-BC, FAANP, FAAN, NP, National Speaker, Senior Faculty with APEA

Learning objectives:

• Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
• Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
• Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial

Disclosures

Product Theater session sponsored by AstraZeneca. This is a promotional education presentation; it will not be certified for continuing medical education credit.

Course Summary

Carolyn Telford, MPAS, PA-C,

Influenza or COVID-19? This program will discuss the optimal ways to diagnose and treat influenza during the COVID-19 pandemic.

Agenda

• Incorporating Tools for Patient Assessment and Diagnostic Testing
• Practice Pearls on Treatment
• Case Presentation: Diagnosing Flu vs COVID
• Live Question and Answer

Learning Objectives

Upon successful completion of the activities, participants will be able to:

• Utilize appropriate diagnostic tools that can differentiate and detect influenza early in its course.
• Incorporate the use of antiviral treatment in patients with influenza based upon efficacy, safety, and propensity for resistance in those who are at normal or high risk for complications.

Target Audience

The intended audience for this activity is nurse practitioners and other health care professionals involved in the management of patients with influenza.

Provider Statement

This continuing education activity is provided by Vindico Medical Education.

Supporter Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

How To Claim Credit

Vindico Medical Education will issue a certificate within 4 weeks of completion to the email address provided at registration.  To claim credit for participation in this activity, you must read the objectives, watch the presentations, and complete the posttest, evaluation, and credit-claim form (sent via electronic survey after the event to the email address provided at registration). Please note that the post-test, evaluation, and credit-claim form will be available only to those participants who view the live activity. The time window to complete the post-test, evaluation, and credit-claim form will be open for only 10 days after the internet live course.

Course Summary

Ruth Carrico, PhD, DNP, FNP-C, CIC, FSHEA, FNAP, Professor and FNP

Charles P. Vega, MD, FAAFP,

Abstract

The management of patients with suspected chronic kidney disease (CKD) involves numerous clinical decisions beginning with considerations for screening and extending through optimal treatment. This activity explores many of these clinical questions encountered by primary care clinicians, with a discussion about 2020 guidelines issued by Kidney Disease – Improving Global Outcomes (KDIGO) and the American Diabetes Association (ADA). While renin-angiotensin-aldosterone (RAAS) inhibitor therapy is well established in the treatment of patients with CKD, the sodium glucose cotransporter-2 (SGLT-2) inhibitors are quickly assuming an important role in these patients, with as well as without diabetes mellitus. Clinical questions related to the use of the SGLT-2 inhibitors in patients with CKD are discussed amidst the growing evidence supporting their important role.

Learning Objectives

At the end of the activity, participants will be able to:

• Identify the risks and consequences of chronic kidney disease.
• Screen appropriately for the presence of CKD in patients at high risk.
• Describe the safety and efficacy of SGLT2 inhibitors on renal outcomes in patients with and without type 2 diabetes mellitus.
• Initiate evidence-based therapy for lowering blood glucose in patients with established kidney disease as recommended in updated guidelines.

Accreditation Statement

The AAFP has reviewed Clinical Decisions in Treating Patients with Chronic Kidney Disease with SGLT-2 Inhibitors and deemed it acceptable for AAFP credit. Term of approval is from 01/01/2021 to 12/31/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):

• 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) - Clinical Decisions in Treating Patients with Chronic Kidney Disease with SGLT-2 Inhibitors

Disclosures

This presentation supported by an educational grant from AstraZeneca Pharmaceuticals LP.  Sponsored by Primary Care Education Consortium. PCEC will issue a certificate of completion within 48 hours of completing the pre/post-tests, to the provided email address. Be sure to print it off for your records as this is not an NPACE session and therefore the certificate will NOT be saved within your NPACE dashboard.

Course Summary

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Family Nurse Practitioner and Owner

In this session, we will discuss the clinical impact and physiology of overactive bladder as well as the latest perspectives on management and treatment.

Disclosures

Product Theater session sponsored by Astellas. This is a promotional education presentation; it will not be certified for continuing medical education credit.

Course Summary

David Staskin, MD, Urology Attending

Learning Objectives 

• Describe current management strategies and identify potential treatments for mild to moderate COVID-19, with a specific focus on vulnerable populations. 
• Evaluate best practices for managing patients with COVID-19 using monoclonal antibodies and other agents, with a focus on efficacy against emerging viral variants. 
• Clinicians require education about treating people with COVID-19 requiring hospitalization. 
• Describe current management strategies and identify potential treatments for COVID-19 requiring hospitalization. 

Accreditation Statement 

This activity will be certified by the Postgraduate Institute for Medicine for a maximum of 1.0 ACCME AMA PRA Category 1 Credit™ and 1.0 ANCC credit. 

Provider Statement 

 This continuing education activity is provided by DKB Med. Jointly provided by Postgraduate Institute for Medicine, the Institute of Johns Hopkins Nursing, and DKBmed, LLC. Supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Course Summary

Stella A. Safo, MD, MPH​, Assistant Professor​

Dinora Chinchilla, MD, MBA, Health Sciences Assistant Clinical Professor

CE Accredited Pre-session Program Complete our free enduring CME activity prior to attending the live presentation. Earn 1.0 CE credit.

Learning Objectives:

This education initiative is designed to equip adult primary care clinicians with evidence-based knowledge and increased competence about how to use diabetes technology and devices to guide and modify treatment approaches for patients with diabetes. Review available diabetes technologies to manage patients with diabetes Discuss how CGMs, connected pens, insulin pumps and integrated devices can be applied in the shared clinical-decision making process to better manage patients with diabetes Select the appropriate diabetes technologies and devices for each patient Incorporate diabetes technologies that are effective in managing patients in special populations.

Provider Statement 

This continuing education activity is provided by AACE. We encourage you to complete our free enduring CME activity prior to attending the live presentation as the information shared at the live course builds upon the material covered in the enduring activity. Please use the following link to access the course: https://buff.ly/3afGBWv. Once you register for this free enduring activity, you can also find the course in your course list at learn.aace.com. 

Course Summary

Matthew J. Levine, MD, FACE, Clinical Endocrinologist, Endocrinology Fellowship Director, Scripps Clinic

Migraine Management for the Nurse Practitioner: Acute and Preventive Therapies to Reduce Burden of Disease

Migraine is an underdiagnosed and undertreated condition, leaving affected individuals struggling to cope with the effects of the disorder. During this Nurse Practitioner Associates for Continuing Education (NPACE) 2021 Virtual Conference you will learn how to better diagnose and treat migraine headaches in a timely and effective manner.

AGENDA

• Patient Identification: Issues and Challenges in the Diagnosis of Migraine
• Managing Migraine from the Nurse Practitioner’s Perspective: Acute and Preventive Treatments
• Case Presentation: Acute/Preventive Treatment for Episodic Migraine
• LIVE Question & Answer

Activity Co-Chairs

Susan Hutchinson, MD Director – Orange County Migraine & Headache Center Irvine, CA

Stewart Tepper, MD, FAHS Professor of Neurology Geisel School of Medicine at Dartmouth Hanover, NH

Provider Statement

This continuing education activity is provided by Vindico Medical Education.

Supporter Statement

This activity is supported by an educational grant from AbbVie Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

How To Claim Credit

To claim credit for participation in this activity, you must read the objectives, watch the presentations, and complete the posttest, evaluation, and credit-claim form (sent via electronic survey after the event to  the email address provided at registration).

Please note: The posttest, evaluation, and credit-claim form will be available only to those participants who view the live activity. Vindico Medical Education will issue a certificate within 4 weeks of completion to the email address provided at registration.

The time window to complete the posttest, evaluation, and credit-claim form will be open for only 10 days after the internet live course. When completing the credit-claim form, the total number of credits selected must be based on the number of hours attended. Your credits will be officially recorded by Vindico Medical Education and stored in a computer database for 6 years.

Course Summary

Susan Hutchinson, MD, UCNS Certified-Headache Director- Orange County Migraine & Headache Center Irvine, CA

Stewart Tepper, MD, FAHS